Problem

The client was preparing to launch a novel oncology orphan drug in a new area in which they had no previous experience, and required identification of key payer account segments and tailored engagement strategy for each segment

Solution

  • A 3-phase approach was employed over the course of 8 months, focusing on the US market:
    • Conducted an influence mapping to understand the roles of key decision-makers and influencers as well as their drivers and priorities
    • Segmented the orphan drug market to profile and prioritize accounts for optimal resource allocation
    • Developed a launch strategy tailored to each segment

Outcome

  • Created a validated influence map that informed the optimal allocation of launch and post-launch resources
  • Developed a detailed database to support analyses and reporting, in addition to the segment profiles and customized segment-based launch strategies
  • Ensured that outputs integrated seamlessly with the client’s existing sales support tools